Stay Updated with VetCare Africa News

Get the latest updates on animal health, new product launches, industry insights, and practical livestock care information from across East Africa.

Join our mailing list to receive useful news and updates straight to your inbox.

Tylosin 20%

Properties

  • Antibiotic formulation containing Tylosin Tartrate 20%.
  • Tylosin belongs to the macrolide group of antibiotics.
  • Has a bacteriostatic mode of action.
  • Acts by binding to the 50S ribosomal subunit, inhibiting bacterial protein synthesis.
  • Provides activity against susceptible bacterial organisms and Mycoplasma.
  • Active against susceptible aerobic and anaerobic bacteria as stated in the supplied product information.

Benefits

  • Provides antimicrobial activity against a range of susceptible bacterial pathogens.
  • Effective against susceptible Staphylococcus and Streptococcus.
  • Provides activity against susceptible Brucella, Pasteurella, Clostridia and Klebsiella.
  • Active against susceptible Haemophilus, Corynebacterium, E. coli and Salmonella.
  • Provides activity against susceptible Mycoplasma.
  • Also indicated against susceptible organisms associated with spirochetosis, actinomycosis and rickettsial

Active Ingredient

  • Tylosin Tartrate — 20%

Pack Size:

  • 25 g sachet
  • 100 g sachet
  • 1 kg sachet

Indications

For the treatment of infections caused by susceptible organisms, including:

  • Staphylococcus
  • β-haemolytic Streptococcus
  • Non-haemolytic Streptococcus
  • Brucella
  • Pasteurella
  • Clostridia
  • Klebsiella
  • Haemophilus
  • Corynebacterium
  • E. coli
  • Salmonella
  • Mycoplasma
  • Actinomyces
  • Rickettsia

Dosage & Administration

Not specified in the supplied product information.

Withdrawal Period

After the last dose:

  • Meat: 5 days
  • Eggs: 5 days

Storage Conditions

Store below 30°C in a dry place away from direct sunlight.

Keep out of reach of children.

Disposal

Dispose of any unused veterinary medicinal product in accordance with local regulatory requirements.

Properties

  • Antibiotic formulation containing Tylosin Tartrate 20%.
  • Tylosin belongs to the macrolide group of antibiotics.
  • Has a bacteriostatic mode of action.
  • Acts by binding to the 50S ribosomal subunit, inhibiting bacterial protein synthesis.
  • Provides activity against susceptible bacterial organisms and Mycoplasma.
  • Active against susceptible aerobic and anaerobic bacteria as stated in the supplied product information.

Benefits

  • Provides antimicrobial activity against a range of susceptible bacterial pathogens.
  • Effective against susceptible Staphylococcus and Streptococcus.
  • Provides activity against susceptible Brucella, Pasteurella, Clostridia and Klebsiella.
  • Active against susceptible Haemophilus, Corynebacterium, E. coli and Salmonella.
  • Provides activity against susceptible Mycoplasma.
  • Also indicated against susceptible organisms associated with spirochetosis, actinomycosis and rickettsial

Active Ingredient

  • Tylosin Tartrate — 20%

Pack Size:

  • 25 g sachet
  • 100 g sachet
  • 1 kg sachet

Indications

For the treatment of infections caused by susceptible organisms, including:

  • Staphylococcus
  • β-haemolytic Streptococcus
  • Non-haemolytic Streptococcus
  • Brucella
  • Pasteurella
  • Clostridia
  • Klebsiella
  • Haemophilus
  • Corynebacterium
  • E. coli
  • Salmonella
  • Mycoplasma
  • Actinomyces
  • Rickettsia

Dosage & Administration

Not specified in the supplied product information.

Withdrawal Period

After the last dose:

  • Meat: 5 days
  • Eggs: 5 days

Storage Conditions

Store below 30°C in a dry place away from direct sunlight.

Keep out of reach of children.

Disposal

Dispose of any unused veterinary medicinal product in accordance with local regulatory requirements.

Tylosin 20%

Quality Assured

Reliable animal health and nutrition support

Specialist Formulation

Developed for targeted product performance

Trusted Support

Professional help for partners and enquiries

TYLOSIN 20% is a bacteriostatic antibiotic formulation containing Tylosin Tartrate, an antibiotic belonging to the macrolide group. It provides activity against a range of susceptible bacterial organisms and Mycoplasma.

Tylosin acts by binding to the 50S ribosomal subunit, thereby inhibiting bacterial protein synthesis. It is indicated for the treatment of infections caused by organisms susceptible to Tylosin Tartrate.

Pack Size: 25 g, 100 g and 1 kg Sachets

Benefits

  • Contains Tylosin Tartrate 20%.
  • Macrolide antibiotic with bacteriostatic activity.
  • Acts by inhibiting bacterial protein synthesis.
  • Provides activity against a range of susceptible bacterial pathogens.
  • Effective against susceptible Mycoplasma.
  • Provides activity against susceptible organisms associated with spirochetosis, actinomycosis and rickettsial infections.

Indications

Tylosin Tartrate is indicated for infections caused by susceptible organisms, including:

  • Staphylococcus
  • β-haemolytic Streptococcus
  • Non-haemolytic Streptococcus
  • Brucella
  • Pasteurella
  • Clostridia
  • Klebsiella
  • Haemophilus
  • Corynebacterium
  • E. coli
  • Salmonella
  • Mycoplasma
  • Actinomyces
  • Rickettsia

Withdrawal Period

After the last dose:

  • Meat: 5 days
  • Eggs: 5 days

Storage Conditions

Store below 30°C in a dry place away from direct sunlight.

Keep out of reach of children.

Disposal

Any unused veterinary medicinal product should be disposed of in accordance with local regulatory requirements.

Pack Sizes

  • 25 g sachet
  • 100 g sachet
  • 1 kg sachet